2.93
-1.68%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Dezhan Healthcare Co
Its shares trade on Shenzhen under the ticker 000813.SZ. It has been listed since 19 May 1998. In the fiscal year to 31 December 2025, it reported revenue of CN¥396.8m and a net loss of CN¥345.4m. At that date it held total assets of CN¥4.87bn and shareholders' equity of CN¥4.64bn.
Dezhan Healthcare Co., Ltd. is engaged in research and development of human life sciences; focusing on cardiovascular and cerebrovascular drugs, anti-cancer drugs, health products, functional beverages, ecological water and other fields. The company is headquartered in Beijing, Beijing. The firm focuses on cardiovascular and cerebrovascular drugs, anti-cancer drugs, health care products, functional beverages, ecological water and other fields. Its subsidiaries optimize the structure of combined products, introduce production lines that meet the production needs of multiple dosage forms according to product development needs, and increase products such as injections, biopharmaceuticals, and Chinese medicine preparations. The firm mainly conducts its businesses in the China market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 19 May 1998
- Employees
- 1,082
- Website
- dezhanhealthcare.com ↗
Leadership
Pay as last reported
- Mr. Zheming WeiChairman of the Board, since 2013CN¥60,000
- Mr. Wei LiuCo-Chairman of the Board, General Manager, since 2016CN¥4.0m
- Ms. Jinghong ZhangChief Financial Officer, Executive Deputy General ManagerCN¥1.5m
- Mr. Ye LiuChief Scientific Officer
- Mr. Jianfeng XiaoDeputy General Manager, Secretary of the Board
- Mr. Shubin WangDeputy General Manager
- Mr. Feng HanDirector
- Ms. Zhongying LiDirector
- Mr. Sinian QiuDirectorCN¥60,000
- Ms. Hailin YanDirector
- Ms. Weihong SunIndependent DirectorCN¥180,000
- Mr. Xin'an WangIndependent DirectorCN¥180,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 19
- Environment
- 22
- Social
- 25
- Governance
- 9
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dezhan Healthcare focuses on cardiovascular and cerebrovascular drugs in China market.
- Dezhan Healthcare develops anti-cancer drugs and health products for Chinese consumers.
- Dezhan Healthcare produces functional beverages and ecological water as part of its product line.
Weaknesses
- Dezhan Healthcare has limited international presence beyond China market.
- Dezhan Healthcare's subsidiaries focus on optimizing product structure without expanding globally.
- Dezhan Healthcare's business is concentrated in China with no mention of overseas markets.
Opportunities
- Dezhan Healthcare can expand into biopharmaceuticals and Chinese medicine preparations.
- Dezhan Healthcare can leverage its R&D in human life sciences for new markets.
- Dezhan Healthcare can introduce production lines for multiple dosage forms to increase product variety.
Threats
- Dezhan Healthcare faces competition from other Chinese pharmaceutical companies.
- Dezhan Healthcare must navigate regulatory challenges in the Chinese pharmaceutical industry.
- Dezhan Healthcare's reliance on China market exposes it to domestic economic fluctuations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.